An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products.
VERDICT
The label
Distribution
read at $125.56
Aflac holds its Distribution at $125.56.
PHPhase · the trend structure carries the Distribution label
INInsiders · no filings inside 60 days, left as found
POPositioning · no disclosures inside 60 days, left as found
OPOptions · no verdict drawn today, left as found
SCScreen · does not pass the values gate
edge confirmed
edge broken
edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
INVESTOR
The investor read · the season, not the day
As held on the ledger · 2026-08-05
Phase
Distribution · caution
Quantitative state
Consolidating, no directional conviction, held for 6 days
Price
$125.56
Valuation
14.35 trailing · 16.64 forward price to earnings
Values screen
FAIL· score 10.0
Beta
0.60
OPPORTUNITY
The opportunity · what the numbers say it is worth
Our framework reads AVOID — it trades above our $115.60 fair value estimate, moderate competitive moat, 27.90% revenue growth.
Read at
$125.56
14.35 P/E · 16.64 fwd
Our fair value
$115.60
8% premium
Analyst target (avg)
$118.00
-6% to current
Target low $98.00Analyst target rangeTarget high $137.00
▲ current $125.56 · | average target
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Current
$125.56
you are here
Conservative
$88.20
-30%
Analyst avg
$118.00
-6%
Our fair value
$115.60
-8%
Analyst high
$137.00
+9%
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Both our model and the Street see limited upside at this price.
Revenue growth
27.90%
Profit margin
25.60%
Debt to equity
48.28
Analyst consensus
Hold · 14 covering
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
SCREEN
The values screen, explained · five checks, plain English
This company is excluded by both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. It fails on both:
The common standard· AAOIFI Used by most halal investing apps✗ DOES NOT PASS
Our stricter standard· asset-based The one Titan applies✗ DOES NOT PASS
Why it fails. The problem is its business activity screen. Because both standards agree on this, it is a clear exclusion, not a borderline case.
Business activityBusiness activity: Financials sectorFail
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
PLAIN
The business, in plain words · what the numbers mean
Aflac Trips the Ethical Screen Despite Solid Numbers
Picture a policyholder in Osaka or Atlanta filing a cancer claim and the payout arrives on time. Aflac has built a decent franchise in supplemental health cover across Japan and the US, with revenue up 28 percent, a 26 percent profit margin and 16 percent ROE. The business carries a moderate moat and trades at 16.5 times forward earnings.
We pass because the stock fails our business activity screen outright. It also sits 8 percent above our fair value of 115 dollars at the current 124.72 dollars, with analysts clustered around a 117 dollar hold target. Strong cash generation does not offset the ethical red flag.
The main risk is that the ethical issue stays unresolved while the shares remain expensive relative to our calculation. Insurance can look steady until a regulatory or reputational shock hits the premium flow. Analysis, not advice.
Screened names in the same industry · explore each on its own page.
TRADE
Where & how to trade · wherever in the world you are
AFL trades on a US exchange. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
TRADER
The trader read · the latest dated commentary
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 5.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (14 analysts) rates it hold, with a mean price target of $112. Entered 2026-07-20 · Accumulation
JOURNAL
The dated journal · newest first, never edited
2026-07-20Accumulation$124.72+5.5%Entry 5
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 5.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (14 analysts) rates it hold, with a mean price target of $112.
2026-07-18Accumulation$118.24+0.0%Entry 4
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (14 analysts) rates it hold, with a mean price target of $112.
2026-07-16Accumulation$118.24+0.0%Entry 3
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (14 analysts) rates it hold, with a mean price target of $112.
2026-07-03Accumulation$118.24+0.0%Entry 2
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
2026-07-02Accumulation$118.24Entry 1
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
INSIDERS
The insider ledger · Form 4 filings, as filed
Most recent filings · AFL
Date
Insider
Title
Type
Shares
Value
2026-05-19
JAPAN POST HOLDINGS CO., LTD.
Beneficial Owner of more than 10% of a Class of Security
50,000
$5,939,992
2026-05-18
JAPAN POST HOLDINGS CO., LTD.
Beneficial Owner of more than 10% of a Class of Security
41,700
$4,939,291
2026-05-15
KENNY THOMAS J
Director
1,740
$202,832
2026-05-15
JAPAN POST HOLDINGS CO., LTD.
Beneficial Owner of more than 10% of a Class of Security
23,500
$2,745,886
2026-05-14
JAPAN POST HOLDINGS CO., LTD.
Beneficial Owner of more than 10% of a Class of Security
24,500
$2,852,290
2026-05-14
COLLINS ARTHUR REGINALD
Director
2,300
$268,065
2026-05-13
JAPAN POST HOLDINGS CO., LTD.
Beneficial Owner of more than 10% of a Class of Security
24,200
$2,791,597
2026-05-12
JAPAN POST HOLDINGS CO., LTD.
Beneficial Owner of more than 10% of a Class of Security
24,300
$2,818,084
2026-05-11
JAPAN POST HOLDINGS CO., LTD.
Beneficial Owner of more than 10% of a Class of Security
